Live Breaking News & Updates on Arbutus Biopharma Company Profile

Stay updated with breaking news from Arbutus biopharma company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FourWorld Capital Management LLC Sells 251,056 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)

FourWorld Capital Management LLC reduced its position in shares of Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 18.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,090,851 shares of the biopharmaceutical company’s stock after selling 251,056 shares during the quarter. Arbutus Biopharma […] ....

United States , Path Wealth Partners , China Universal Asset Management Co , Arbutus Biopharma Company Profile , Arbutus Biopharma Co , Barclays Plc , Arbutus Biopharma Corporation , Sg Americas Securities , Fourworld Capital Management , Arbutus Biopharma , Free Report , World Capital Management , Universal Asset Management , Get Free Report , Biopharma Corporation , Arbutus Biopharma Daily ,

Clear Harbor Asset Management LLC Boosts Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS)

Clear Harbor Asset Management LLC grew its position in Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 148.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 131,761 shares of the biopharmaceutical company’s stock after purchasing an additional 78,761 shares during the period. Clear Harbor Asset Management LLC’s holdings in Arbutus Biopharma were worth […] ....

United States , Hudson Bay , Jefferies Financial Group Inc , Moneta Group Investment Advisors , Arbutus Biopharma Corporation , Arbutus Biopharma Co , American International Group Inc , Clear Harbor Asset Management , Arbutus Biopharma Company Profile , Arbutus Biopharma , Free Report , Harbor Asset Management , Financial Group , Montreal Can , Bay Capital Management , International Group , Group Investment Advisors , Get Free Report , Biopharma Corporation , Visit Holdingschannel , Arbutus Biopharma Daily , Nasdaq Abus , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Arbutus Biopharma (NASDAQ:ABUS) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Arbutus Biopharma (NASDAQ:ABUS – Free Report) in a research report released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the stock. HC Wainwright reiterated a buy rating and set a $6.00 target price on shares […] ....

United States , Simplicity Solutions , Principal Financial Group Inc , Arbutus Biopharma Corporation , Arbutus Biopharma Company Profile , Bleakley Financial Group , Pricet Rowe Associates Inc , Verition Fund Management , Arbutus Biopharma , Free Report , Biopharma Stock Down , Fund Management , Financial Group , Principal Financial Group , Get Free Report , Biopharma Corporation , Arbutus Biopharma Daily , Nasdaq Abus , Initiated Coverage , Stocknews Com ,

Arbutus Biopharma (NASDAQ:ABUS) Receives New Coverage from Analysts at StockNews.com

Arbutus Biopharma (NASDAQ:ABUS) Receives New Coverage from Analysts at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Nuveen Asset Management , Wells Fargo Company , Arbutus Biopharma Corporation , Arbutus Biopharma Company Profile , Arbutus Biopharma , Free Report , Asset Management , Capital Management , Hudson Bay Capital Management , Bay Capital Management , Get Free Report , Biopharma Corporation , Arbutus Biopharma Daily ,

Arbutus Biopharma's (ABUS) Buy Rating Reiterated at Chardan Capital

Arbutus Biopharma's (ABUS) Buy Rating Reiterated at Chardan Capital
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Arete Wealth Advisors , Arbutus Biopharma Company Profile , Jpmorgan Chase Co , Arbutus Biopharma Corporation , Ameriprise Financial Inc , York Mellon Corp , Arbutus Biopharma , Get Free Report , Chardan Capital , New York Mellon Corp , Montreal Can , Wealth Advisors , Biopharma Corporation , Arbutus Biopharma Daily ,